BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23512947)

  • 21. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
    Ghosh MG; Thompson DA; Weigel RJ
    Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genomic profile of HER2-amplified breast cancers: the influence of ER status.
    MarchiĆ² C; Natrajan R; Shiu KK; Lambros MB; Rodriguez-Pinilla SM; Tan DS; Lord CJ; Hungermann D; Fenwick K; Tamber N; Mackay A; Palacios J; Sapino A; Buerger H; Ashworth A; Reis-Filho JS
    J Pathol; 2008 Dec; 216(4):399-407. PubMed ID: 18810758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear factor-kappaB signature of inflammatory breast cancer by cDNA microarray validated by quantitative real-time reverse transcription-PCR, immunohistochemistry, and nuclear factor-kappaB DNA-binding.
    Van Laere SJ; Van der Auwera I; Van den Eynden GG; Elst HJ; Weyler J; Harris AL; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3249-56. PubMed ID: 16740744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
    Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
    Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of menopausal status from estrogen-related gene expression in benign breast tissue.
    Lee O; Helenowski IB; Chatterton RT; Jovanovic B; Khan SA
    Breast Cancer Res Treat; 2012 Feb; 131(3):1067-76. PubMed ID: 22101408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poor hormone receptor expression in East African breast cancer: evidence of a biologically different disease?
    Bird PA; Hill AG; Houssami N
    Ann Surg Oncol; 2008 Jul; 15(7):1983-8. PubMed ID: 18408976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demethylation of the estrogen receptor gene in estrogen receptor-negative breast cancer cells can reactivate estrogen receptor gene expression.
    Ferguson AT; Lapidus RG; Baylin SB; Davidson NE
    Cancer Res; 1995 Jun; 55(11):2279-83. PubMed ID: 7538900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of miR-18a and miR-210 in Normal Breast Tissue as Candidate Biomarkers of Breast Cancer Risk.
    Shidfar A; Costa FF; Scholtens D; Bischof JM; Sullivan ME; Ivancic DZ; Vanin EF; Soares MB; Wang J; Khan SA
    Cancer Prev Res (Phila); 2017 Jan; 10(1):89-97. PubMed ID: 27789587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated expression of cancer/testis antigen FSIP1 in ER-positive breast tumors.
    Chapman KB; Prendes MJ; Kidd JL; Sternberg H; West MD; Wagner J
    Biomark Med; 2013 Aug; 7(4):601-11. PubMed ID: 23905897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor alpha expression in normal human breast epithelium is consistent over time.
    Khan SA; Yee KA; Kaplan C; Siddiqui JF
    Int J Cancer; 2002 Dec; 102(4):334-7. PubMed ID: 12402301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium.
    Graham K; Ge X; de Las Morenas A; Tripathi A; Rosenberg CL
    Clin Cancer Res; 2011 Jan; 17(2):236-46. PubMed ID: 21059815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial least squares based analysis of pathways in recurrent breast cancer.
    Gao QG; Li ZM; Wu KQ
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2159-65. PubMed ID: 23893181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase.
    Hu H; Wang J; Gupta A; Shidfar A; Branstetter D; Lee O; Ivancic D; Sullivan M; Chatterton RT; Dougall WC; Khan SA
    Breast Cancer Res Treat; 2014 Aug; 146(3):515-23. PubMed ID: 25007964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers.
    Zhou X; Shi T; Li B; Zhang Y; Shen X; Li H; Hong G; Liu C; Guo Z
    PLoS One; 2013; 8(7):e70017. PubMed ID: 23875016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray.
    Nagahata T; Onda M; Emi M; Nagai H; Tsumagari K; Fujimoto T; Hirano A; Sato T; Nishikawa K; Akiyama F; Sakamoto G; Kasumi F; Miki Y; Tanaka T; Tsunoda T
    Cancer Sci; 2004 Mar; 95(3):218-25. PubMed ID: 15016320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence.
    Fackler MJ; Umbricht CB; Williams D; Argani P; Cruz LA; Merino VF; Teo WW; Zhang Z; Huang P; Visvananthan K; Marks J; Ethier S; Gray JW; Wolff AC; Cope LM; Sukumar S
    Cancer Res; 2011 Oct; 71(19):6195-207. PubMed ID: 21825015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array.
    Lyng MB; Laenkholm AV; Pallisgaard N; Vach W; Knoop A; Bak M; Ditzel HJ
    Cell Oncol; 2007; 29(5):361-72. PubMed ID: 17726259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer.
    Cheng C; Fu X; Alves P; Gerstein M
    Genome Biol; 2009; 10(9):R90. PubMed ID: 19723326
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrative genomic analysis reveals functional diversification of APOBEC gene family in breast cancer.
    Zhang Y; Delahanty R; Guo X; Zheng W; Long J
    Hum Genomics; 2015 Dec; 9():34. PubMed ID: 26682542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.